SARS-CoV-2 | Inception 3/3

Monitoring the proportion of the population infected by SARS-CoV-2

The Lancet Public Health Hozé N, Paireau J, Lapidus N, Tran Kiem C, Salje H, Gianluca Severi, Touvier M, Zins M, de Lamballerie X,...

Evaluating the impact of curfews and other measures on SARS-CoV-2 transmission in French Guiana

Nat Commun Andronico A, Tran Kiem C, Paireau J, Succo T, Bosetti P, Lefrancq N, Nacher M, Djossou F, Sanna A, Flamand C, Salje H,...

Inhibition of the replication of SARSCoV-2 in human cells by the FDA-approved drug chlorpromazine

Int J Antimicrob Agents Plaze M, Attali D, Prot M, Petit AC, Blatzer M, Vinckiera F, Levillayer L, Chiaravalli J, Perin-Dureau F, Cachiai...

Impact of mass testing during an epidemic rebound of SARS-CoV-2: a modelling study

Euro Surveill Bosetti P, Tran Kiem C, Yazdanpanah Y, Fontanet A, Lina B, Colizza V, Cauchemez S We used a mathematical model to evaluate...

Age-specific mortality and immunity patterns of SARS-CoV-2

Nature O’Driscoll M, Dos Santos GR, Wang L, Cummings DAT, Azman AS, Paireau J, Fontanet A, Cauchemez S, Salje H Estimating the size of...

Age-specific mortality and immunity patterns of SARS-CoV-2

Published in Nature O’Driscoll M, Dos Santos GR, Wang L, Cummings DAT, Azman AS, Paireau J, Fontanet A, Cauchemez S, Salje H Estimating...